-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ironwood Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Ironwood Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.27M, a 2.18% decline year-over-year.
- Ironwood Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$27.7M, a 426% decline year-over-year.
- Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was -$2.64M, a 227% decline from 2022.
- Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $2.09M.
- Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$31.6M, a 7.27% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)